14
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6595 |
Moexipril hydrochloride
莫昔普利盐酸盐,Moexipril HCl,RS-10085,SPM 925,CI-925 |
Apoptosis; RAAS | Apoptosis; Endocrinology/Hormones |
Moexipril hydrochloride (Moexipril HCl) 是一种有口服活性的,不含巯基的血管紧张素转化酶抑制剂,可治疗高血压和充血性心力衰竭。 | |||
T3216 |
Selexipag
NS-304,ACT-293987,赛乐西帕,Uptravi |
Others; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Others |
Selexipag (ACT-293987) 是前列环素受体激动剂,可引起肺血管舒张,用于治疗肺动脉高压。 | |||
T27821 |
Lexipafant
ISV-611,GR-167089,DO-6,BB-882,DO6,BB882 |
||
Lexipafant is a platelet-activating factor (PAF) receptor antagonist. | |||
T71555 |
Moexipril ethyl ester
|
||
Moexipril ethyl ester is a long-acting, non-sulfhydryl angiotensine-converting enzyme inhibitor. | |||
T69620 |
Demexiptiline
|
||
Demexiptiline is a tricyclic antidepressant used in France for the treatment of depression. It acts primarily as a norepinephrine reuptake inhibitor similarly to desipramine. | |||
T63377 |
Moexipril
|
||
Moexipril 是口服具有活力的血管紧张素转换酶 (ACE) 抑制剂。Moexipril 易于透过脂质膜,靶向血浆和组织ACE,改善内皮功能障碍,具有神经保护活性,能够用于研究心血管疾病。 | |||
TMIH-0519 |
Selexipag Active Metabolite-d7
|
||
Selexipag Active Metabolite-d7 是 Selexipag Active Metabolite 的氘代化合物。Selexipag Active Metabolite 的 CAS 号为 475085-57-5。MRE269 是一种口服的长效前列环素受体激动剂前药,是 Selexipag 的活性代谢物,用于治疗肺动脉高压。 | |||
T31736 |
Exiproben
DCH 21 |
||
Exiproben is a biochemical. | |||
T67997 |
mexiprostil
|
||
mexiprostil 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T67997,CAS号为 88980-20-5。 | |||
T83766 |
Moexiprilat
RS 10029 |
||
Moexiprilat是一种血管紧张素转换酶(ACE; IC50 = 2.1 nM)的抑制剂,也是前药moexipril的一种活性代谢产物。通过侧链酯水解作用,在体内从moexipril转化而来。Moexiprilat (10 nM)能防止初生大鼠心脏成纤维细胞在雌激素或血管紧张素II刺激下的增殖。在以每天50 mg/kg剂量给药的去卵巢小鼠中,降低平均动脉血压,并增加心房钠尿肽水平,这是高血压的一个标志。 | |||
TMIH-0520 |
Selexipag-d7
|
||
Selexipag-d7 是 Selexipag 的氘代化合物。Selexipag 的 CAS 号为 475086-01-2。Selexipag 是前列环素受体激动剂,可引起肺血管舒张,用于治疗肺动脉高压。 | |||
T31737 |
Exiproben sodium salt
DCH 21,DCH-21,DCH21 |
||
Exiproben sodium salt is a biochemical. | |||
T70883 |
Moexipril-d5
|
||
Moexipril-d5 intended for use as an internal standard for the quantification of moexipril by GC- or LC-MS. Moexipril is a prodrug form of the angiotensin converting enzyme (ACE) inhibitor moexiprilat. It is converted to moexiprilat in vivo by side chain ester hydrolysis. Moexipril inhibits ACE in a cell-free assay (IC50 = 2.7 µM for the rabbit enzyme). It also inhibits phosphodiesterase 4 (IC50s = 38, 160, and 230 µM for PDE4B2, PDE4A5 and PDE4D5, respectively). Moexipril (0.1-30 mg/kg per day) ... | |||
T70884 |
Moexipril methyl ester
|
||
Moexipril methyl ester is a long-acting, non-sulfhydryl angiotensine-converting enzyme inhibitor. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04260 |
p38 Protein, Human, Recombinant (His)
mitogen-activated protein kinase 14,CSPB1,PRKM14,RK,p38α,CSB... |
Human | Baculovirus Insect Cells |
MAPK14 contains 1 protein kinase domain and belongs to the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation, and development. MAPK14 can be detected in the brain, heart, placenta, pancreas, and skeletal muscle and it is expressed to a lesser extent in the lung, liver, and kidney. MAPK14 is activated by various environmental stresses ... |